Nomograms for Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection

被引:215
|
作者
Yang, Hwai-I
Sherman, Morris
Su, Jun
Chen, Pei-Jer
Liaw, Yun-Fan
Iloeje, Uchenna H.
Chen, Chien-Jen [1 ]
机构
[1] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan
关键词
LIVER FIBROSIS; BIOCHEMICAL MARKERS; HEART-DISEASE; PREDICTION; CIRRHOSIS; SCORE; PREVENTION; GENOTYPE; MODELS; LEVEL;
D O I
10.1200/JCO.2009.27.4456
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Counseling patients with chronic hepatitis B virus (HBV) on their individual risk of liver disease progression is challenging. This study aimed to develop nomograms for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B. Patients and Methods Two thirds of the Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer Hepatitis B Virus (REVEAL-HBV) study cohort was allocated for model derivation (n = 2,435), and the remaining third was allocated for model validation (n = 1,218). Previously confirmed independent risk predictors included in three Cox proportional hazards regression models were sex, age, family history of hepatocellular carcinoma, alcohol consumption habit, serum ALT level, hepatitis B envelope antigen (HBeAg) serostatus, serum HBV DNA level, and HBV genotype. Regression coefficients were rounded into integer risk scores, and predicted risk over 5- and 10-year periods for each risk score was calculated and depicted in nomograms. The predictive accuracy was evaluated using the area under the receiver operating characteristic curve (AUROC) and the correlation between predicted and observed hepatocellular carcinoma risk. Results All selected risk predictors were statistically significant in all models. In each model, either HBeAg seropositivity or HBeAg seronegativity with high viral load (HBV DNA level >= 100,000 copies/mL) and genotype C infection had the highest risk scores. All AUROCs for risk prediction nomogram were >= 0.82 in both model derivation and validation sets. The correlation coefficients between the observed hepatocellular carcinoma risk and the nomogram-predicted risk were greater than 0.90 in all model derivation and validation sets. Conclusion These easy-to-use nomograms based on noninvasive clinical characteristics can accurately predict the risk of hepatocellular carcinoma in patients with chronic hepatitis B. They may facilitate risk communication between patients and clinicians.
引用
下载
收藏
页码:2437 / 2444
页数:8
相关论文
共 50 条
  • [1] Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection
    Ito, Kenichi
    Arai, Makoto
    Imazeki, Fumio
    Yonemitsu, Yutaka
    Bekku, Dan
    Kanda, Tatsuo
    Fujiwara, Keiichi
    Fukai, Kenichi
    Sato, Kenichi
    Itoga, Sakae
    Nomura, Fumio
    Yokosuka, Osamu
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 (02) : 243 - 249
  • [2] Update on the risk of hepatocellular carcinoma in chronic hepatitis B virus infection
    Hsu A.
    Lai C.-L.
    Yuen M.-F.
    Current Hepatitis Reports, 2011, 10 (2) : 106 - 111
  • [3] Prevention of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection
    Kim, Beom Kyung
    Han, Kwang-Hyub
    Ahn, Sang Hoon
    ONCOLOGY, 2011, 81 : 41 - 49
  • [4] Risk Factors and Comorbidities Associated With Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection
    Weidemann, Helen
    Yeh, Kristen
    Hunter, Krystal
    Roy, Satyajeet
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2024, 15
  • [5] RISK PREDICTION MODEL OF HEPATOCELLULAR CARCINOMA IN KOREAN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION
    Song, I. H.
    Choo, Y. K.
    Shin, H. D.
    Kim, S. B.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S252 - S252
  • [6] STATINS AND THE RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HEPATITIS B VIRUS INFECTION
    Tsan, Y.
    Lee, C.
    Wang, J.
    Chen, P.
    VALUE IN HEALTH, 2012, 15 (07) : A602 - A603
  • [7] Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
    Tsan, Yu-Tse
    Lee, Chang-Hsing
    Wang, Jung-Der
    Chen, Pau-Chung
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (06) : 623 - 630
  • [8] Hepatitis B virus infection and the risk of hepatocellular carcinoma
    Tan, Ya-Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (44) : 4853 - 4857
  • [10] Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma
    Kew, M. C.
    PATHOLOGIE BIOLOGIE, 2010, 58 (04): : 273 - 277